Toxicology and applied pharmacology 394 114958-114958 2020年5月 [査読有り]
Drug-induced liver injury (DILI) can cause hepatic failure and result in drug withdrawal from the market. It has host-related and compound-dependent mechanisms. Preclinical prediction of DILI risk is very challenging and safety assessments based o...
Sakai Y   Iwao T   Susukida T   Nukaga T   Takemura A   Sekine S   Ito K   Matsunaga T   
Drug metabolism and pharmacokinetics 34(4) 264-271 2019年8月 [査読有り]
Akinori Takemura   Simin Gong   Shuichi Sekine   Kousei Ito   
Toxicology 423 32-41 2019年7月 [査読有り]
The liver performs a variety of essential functions; hence drug-induced liver injury (DILI) is a serious concern that can ultimately lead to the withdrawal of a drug from the market or discontinuation of drug development. However, the mechanisms o...
Sato T   Takemura A   Ikeyama Y   Sakamaki Y   Mimata A   Aoyagi H   Aizaki H   Sekine S   Ito K   
Akinori Takemura   Aya Izaki   Shuichi Sekine   Kousei Ito   
TOXICOLOGY IN VITRO 35 121-130 2016年9月 [査読有り]
Idiosyncratic drug-induced liver injury is a clinical concern with serious consequences. Although many preclinical screening methods have been proposed, it remains difficult to identify compounds associated with this rare but potentially fatal liv...